UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome

Cancers, 2023-01, Vol.15 (2), p.391

2023

Volltextzugriff (PDF)

Changing predictor measurement procedures affected the performance of prediction models in clinical examples

Journal of clinical epidemiology, 2020-03, Vol.119, p.7-18

2020

Volltextzugriff (PDF)

Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access

Genetics in medicine, 2022-06, Vol.24 (6), p.1196-1205

2022

Volltextzugriff (PDF)

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1579-1579

2020

Volltextzugriff (PDF)

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.678-678

2020

Volltextzugriff (PDF)

Clinical factors associated with urinary tract cancers (UTCs) among Lynch syndrome (LS) patients (Pts)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1517-1517

2018

Volltextzugriff (PDF)

Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS779-TPS779

2020

Volltextzugriff (PDF)

Identification of Lynch syndrome (LS) in patients (pts) without prior LS-associated cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1521-1521

2016

Volltextzugriff (PDF)

Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1512-1512

2018

Volltextzugriff (PDF)

Prevalence of germline cancer susceptibility gene mutations in a consecutive series of 799 colorectal cancer (CRC) patients (pts)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1501-1501

2016

Volltextzugriff (PDF)

Abstract 4272: Mutations in RABL3 alter RAS prenylation and are associated with hereditary pancreatic cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4272-4272

2017

Volltextzugriff (PDF)

Therapy-associated polyposis – a novel form of acquired gastrointestinal polyposis

Clinical gastroenterology and hepatology, 2013-12, Vol.12 (6), p.1046-1050

2013

Volltextzugriff (PDF)

Cancer risks and mutation spectrum of mismatch repair genes in African American families with Lynch syndrome

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.1530-1530

2013

Volltextzugriff (PDF)

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2165-2172

2017

Volltextzugriff (PDF)

Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome

Clinical gastroenterology and hepatology, 2020-04, Vol.18 (4), p.830-837.e1

2020

Volltextzugriff (PDF)

Tu1018 A MIXED METHODS APPROACH TO ASSESSING BARRIERS AND FACILITATORS TO CANCER GENETICS CARE IN BLACK AND LATINO/A/X INDIVIDUALS AFFECTED BY PANCREATIC CANCER: THE RACIAL/ETHNIC GENETIC EDUATION, RISK ASSESSMENT, AND TESTING (REGENERATE) STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1221-S-1222

2024

Volltextzugriff (PDF)

Implementing systematized patient-facing Lynch syndrome (LS) risk assessment in oncology using the electronic health record (EHR) system

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10503-10503

2022

Volltextzugriff (PDF)

Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing

Journal of clinical oncology, 2020-12, Vol.38 (34), p.4086-4094

2020

Volltextzugriff (PDF)

Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10523-10523

2023

Volltextzugriff (PDF)

Mo1020 RACIAL/ETHNIC EQUITY IN GENETIC EDUCATION, RISK ASSESSMENT, AND TESTING (REGENERATE) AMONG BLACK AND LATINO/A/X COMMUNITIES AT-RISK FOR PANCREATIC CANCER – PRELIMINARY FINDINGS FROM ONLINE FOCUS GROUPS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-733-S-734

2023

Volltextzugriff (PDF)

Tu1212 RELEVANT HETEROGENEITY IN MISMATCH REPAIR DEFICIENT TUMORS

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1020-S-1020

2020

Volltextzugriff (PDF)

PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer

Familial cancer, 2023-10, Vol.22 (4), p.459-465

2023

Volltextzugriff (PDF)

Neoplasia detection via colonoscopic surveillance among young patients with MSH6 and PMS2-associated Lynch syndrome

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10516-10516

2023

Volltextzugriff (PDF)

264 REMOTE GENETIC EDUCATION, RISK ASSESSMENT, AND TESTING (GENERATE) FOR PANCREATIC CANCER: A RANDOMIZED CLINICAL TRIAL

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-45-S-46

2023

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome

Changing predictor measurement procedures affected the performance of prediction models in clinical examples

Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Clinical factors associated with urinary tract cancers (UTCs) among Lynch syndrome (LS) patients (Pts)

Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study

Identification of Lynch syndrome (LS) in patients (pts) without prior LS-associated cancer

Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Prevalence of germline cancer susceptibility gene mutations in a consecutive series of 799 colorectal cancer (CRC) patients (pts)

Abstract 4272: Mutations in RABL3 alter RAS prenylation and are associated with hereditary pancreatic cancer

Therapy-associated polyposis – a novel form of acquired gastrointestinal polyposis

Cancer risks and mutation spectrum of mismatch repair genes in African American families with Lynch syndrome

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome

Tu1018 A MIXED METHODS APPROACH TO ASSESSING BARRIERS AND FACILITATORS TO CANCER GENETICS CARE IN BLACK AND LATINO/A/X INDIVIDUALS AFFECTED BY PANCREATIC CANCER: THE RACIAL/ETHNIC GENETIC EDUATION, RISK ASSESSMENT, AND TESTING (REGENERATE) STUDY

Implementing systematized patient-facing Lynch syndrome (LS) risk assessment in oncology using the electronic health record (EHR) system

Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing

Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients

Mo1020 RACIAL/ETHNIC EQUITY IN GENETIC EDUCATION, RISK ASSESSMENT, AND TESTING (REGENERATE) AMONG BLACK AND LATINO/A/X COMMUNITIES AT-RISK FOR PANCREATIC CANCER – PRELIMINARY FINDINGS FROM ONLINE FOCUS GROUPS

Tu1212 RELEVANT HETEROGENEITY IN MISMATCH REPAIR DEFICIENT TUMORS

Sa1173 A RANDOMIZED TRIAL OF TWO REMOTE HEALTHCARE DELIVERY MODELS ON THE UPTAKE OF GENETIC TESTING AND IMPACT ON PATIENT-REPORTED PSYCHOLOGICAL OUTCOMES IN FAMILIES WITH PANCREATIC CANCER: THE GENETIC EDUCATION, RISK ASSESSMENT, AND TESTING (GENERATE) STUDY

PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer

Neoplasia detection via colonoscopic surveillance among young patients with MSH6 and PMS2-associated Lynch syndrome

264 REMOTE GENETIC EDUCATION, RISK ASSESSMENT, AND TESTING (GENERATE) FOR PANCREATIC CANCER: A RANDOMIZED CLINICAL TRIAL

Aktive Filter

Suchergebnisse filtern